InvestorsHub Logo
icon url

namtae

12/21/17 10:58 AM

#14983 RE: laraz5 #14982

Why would sophisticated investors throw away $4m in Aug on a worthless, failed drug ? Are they ignorant and unable to conduct simple DD?

Thoughts?
icon url

zen222

12/21/17 12:13 PM

#14987 RE: laraz5 #14982

Holy shit! There's so much wrong with that I don't know where to begin. LOL!

For any folks who don't already know, Oncolix's product is the potential multi-billion dollar blockbuster drug Prolanta™ which was given Orphan Drug Status designation by the FDA for the treatment of ovarian cancer that is about to complete Phase I of its clinical trial and is all but guaranteed approval and to commence Phase II shortly thereafter. Prolanta™ is not only showing almost zero side effects but is also exhibiting evidence of efficacy (tumor reduction) in the low dose patients.

No other company (Novartis included) has EVER had Prolanta™ and Prolanta™ has NEVER failed. Continuously saying false nonsense doesn't make it true.

There are multiple participants, saying that no patients are participating in Phase I trial of Prolanta™ is pure fiction.

Phase I trial STILL has not yet completed and Redman STILL isn't hiding no matter how many times the opposite is repeated.

Lastly, ONCX is the furthest thing from "an empty shell", case closed.

icon url

BLight1911

12/21/17 1:21 PM

#14988 RE: laraz5 #14982

One thing at a time...Prolanta FDA trial is still ongoing. Any statement saying otherwise is completely false.

https://clinicaltrials.gov/ct2/show/NCT02534922